SCHEMBL8501180

SCHEMBL8501180

Clc1cc2cc(Br)cnc2cc1Cl

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDGFRB P09619 2/20 0.46
PDGFRA P16234 2/20 0.46
DYRK1A Q13627 3/20 0.39
PLAU P00749 1/20 0.39
MMP1 P03956 1/20 0.36
MMP2 P08253 1/20 0.36
MMP3 P08254 1/20 0.36
HTT P42858 3/20 0.35
KMT2A Q03164 1/20 0.35
MAPK13 O15264 1/20 0.34
CDK1 P06493 1/20 0.34
PIM1 P11309 1/20 0.34
PIM3 Q86V86 1/20 0.34
CLK4 Q9HAZ1 1/20 0.34
ALPL P05186 1/20 0.33
MALT1 Q9UDY8 1/20 0.33
SMN1; SMN2 Q16637 2/20 0.32
ALDH1A1 P00352 2/20 0.32
CASP6 P55212 1/20 0.32
MAPT P10636 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3222941 0.84 PLAU (0.39) PDGFRBPDGFRADYRK1APLAUMMP1
SCHEMBL18571804 0.84 PLAU (0.39) PDGFRBPDGFRADYRK1APLAUHTT
SCHEMBL3214752 0.80 PDGFRB (0.49) PDGFRBPDGFRAKMT2AMALT1SMN1; SMN2
SCHEMBL18318661 0.80 PDGFRB (0.49) PDGFRBPDGFRAKMT2AMALT1SMN1; SMN2
SCHEMBL23892609 0.77 GRM5 (0.39) PDGFRBPDGFRAMALT1SMN1; SMN2MAPT
SCHEMBL29536975 0.77 DYRK1A (0.38) DYRK1APLAUHTTKMT2AALPL
SCHEMBL15272535 0.77 DYRK1A (0.38) DYRK1APLAUHTTKMT2AALPL
SCHEMBL9376307 0.76 PDGFRB (0.42) PDGFRBPDGFRAMALT1ALDH1A1
SCHEMBL789944 0.75 PDGFRB (0.39) PDGFRBPDGFRADYRK1AALPLMALT1
SCHEMBL10688343 0.75 PDGFRB (0.54) PDGFRBPDGFRADYRK1AHTTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE36256-E ADMINISTERING ARYL-SUBSTITUTED QUINOXALINE DERIVATIVES AS ANTIPROLIFERATIVE, ANTICARCINOGENIC AND ANTITUMOR AGENTS RHONE-POULENC RORER PHARMACEUTICALS, INC. (US) 1999-07-20 US disclosed
US-5795889-A INHIBITING CELL GROWTH WITH ENZYME INHIBITORS FOR SKIN DISORDERS RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1998-08-18 US disclosed
US-5656643-A QUINOLIN PYRIDINE DERIVATIVES; USEFUL FOR TREATING CANCER, LEKEMIA, PSORIASIS, INFLAMMATORY DISODERS, BONE DISORDERS, ATHEROSCLEROSIS AND RESTENOSIS; CONTROLLS CELLULAR REPRODUCTION RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1997-08-12 US disclosed
US-5646153-A INHIBITING ABNORMAL CELL PROLIFERATION RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1997-07-08 US disclosed
US-5480883-A Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1996-01-02 US disclosed
US-5409930-A Inhibits abnoramal cell proliferation; dimethoxyquinoline/ dimethylquinoline/ quinolineoxide/ and quinoxaline derivatives RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1995-04-25 US disclosed
WO-1992020642-A1 BIS MONO-AND BICYCLIC ARYL AND HETEROARYL COMPOUNDS WHICH INHIBIT EGF AND/OR PDGF RECEPTOR TYROSINE KINASE RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) 1992-11-26 WO disclosed